Cargando…

Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo

There is a paucity of efficacious new compounds to treat neuropsychiatric disorders. We present a novel approach to neuropsychiatric drug discovery based on high-content characterization of druggable signaling network responses at the single-cell level in patient-derived lymphocytes ex vivo. Primary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lago, Santiago G., Tomasik, Jakub, van Rees, Geertje F., Steeb, Hannah, Cox, David A., Rustogi, Nitin, Ramsey, Jordan M., Bishop, Joshua A., Petryshen, Tracey, Haggarty, Stephen J., Vázquez-Bourgon, Javier, Papiol, Sergi, Suarez-Pinilla, Paula, Crespo-Facorro, Benedicto, van Beveren, Nico J., Bahn, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506238/ https://www.ncbi.nlm.nih.gov/pubmed/31086815 http://dx.doi.org/10.1126/sciadv.aau9093

Ejemplares similares

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers
por: Zaki, Jihan K., et al.
Publicado: (2022)

Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis
por: Muntané, Gerard, et al.
Publicado: (2023)

Multimodel inference for biomarker development: an application to schizophrenia
por: Cooper, Jason D., et al.
Publicado: (2019)

Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review
por: Roiz-Santiañez, Roberto, et al.
Publicado: (2015)

Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots
por: Cooper, Jason D., et al.
Publicado: (2017)

Cervical cancer screening and psychosis: a longitudinal retrospective study comparing women with schizophrenia spectrum disorders and the general population
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2022)

A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2014)

Brief greeting and shared vision()
por: Crespo-Facorro, Benedicto
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis
por: Pistis, Giorgio, et al.
Publicado: (2022)

Towards reproducible MRM based biomarker discovery using dried blood spots
por: Ozcan, Sureyya, et al.
Publicado: (2017)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

Functional patient-derived cellular models for neuropsychiatric drug discovery
por: Lago, Santiago G., et al.
Publicado: (2021)

T175. A 10-YEAR LONGITUDINAL STUDY OF GREY MATTER VOLUME IN FIRST EPISODE OF NON-AFFECTIVE PSYCHOSIS
por: Tordesillas-Gutiérrez, Diana, et al.
Publicado: (2018)

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2022)

Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2015)

Altered gene expression in antipsychotic-induced weight gain
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2019)

Sex differences in gene expression related to antipsychotic induced weight gain
por: Sainz, Jesus, et al.
Publicado: (2019)

Childhood trauma and substance use underlying psychosis: a systematic review
por: Setién-Suero, Esther, et al.
Publicado: (2020)

Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2016)

Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2021)

Understanding sex differences in long-term outcomes after a first episode of psychosis
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2020)

F101. CANNABIS USE AND HEPATIC STEATOSIS IN PSYCHOSIS: RESULTS FROM A 3-YEAR LONGITUDINAL STUDY
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2018)

Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2018)

Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2020)

Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program
por: Pardo-de-Santayana, Guillermo, et al.
Publicado: (2020)

Blood Gene Expression Profile Predicts Response to Antipsychotics
por: Sainz, Jesus, et al.
Publicado: (2018)

Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates
por: Balanzá-Martínez, Vicent, et al.
Publicado: (2015)

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2019)

Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients
por: Ramsey, Jordan M., et al.
Publicado: (2013)

T72. VERBAL MEMORY AND VOXEL BASED MORPHOMETRY IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS: A PROCESS ORIENTED APPROACH
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

F81. AGE OF ONSET OF CANNABIS USE AND COGNITIVE FUNCTION IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS PATIENTS: 3-YEAR FOLLOW-UP OUTCOME
por: Setién-Suero, Esther, et al.
Publicado: (2018)

F124. SEX DIFFERENCES IN OUTCOME IN FIRST EPISODE PSYCHOSIS PATIENTS: A 10-YEAR FOLLOW-UP STUDY
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review
por: Gallardo-Ruiz, Ruth, et al.
Publicado: (2019)

COVID-19 Infection During Pregnancy and Risk of Neurodevelopmental Disorders in Offspring: Time for Collaborative Research
por: López-Díaz, Álvaro, et al.
Publicado: (2021)

Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study
por: Juncal-Ruiz, Maria, et al.
Publicado: (2020)

Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals
por: Han, Sung Yeon Sarah, et al.
Publicado: (2019)

Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression
por: Tomasik, Jakub, et al.
Publicado: (2023)

Temporal proteomic profiling of postnatal human cortical development
por: Breen, Michael S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ic4rr8mfuk2suht0t5s5ipidts